These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27266389)

  • 1. Interaction between platelets and endothelial progenitor cells via LPA-Edg-2 axis is augmented by PPAR-δ activation.
    Han JK; Kim BK; Won JY; Shin Y; Choi SB; Hwang I; Kang J; Lee HJ; Koh SJ; Lee J; Hur J; Cho HJ; Chae IH; Oh BH; Park YB; Kim HS
    J Mol Cell Cardiol; 2016 Aug; 97():266-77. PubMed ID: 27266389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
    Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
    Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-δ activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks.
    Han JK; Kim HL; Jeon KH; Choi YE; Lee HS; Kwon YW; Jang JJ; Cho HJ; Kang HJ; Oh BH; Park YB; Kim HS
    Eur Heart J; 2013 Jun; 34(23):1755-65. PubMed ID: 21920965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.
    Piqueras L; Reynolds AR; Hodivala-Dilke KM; Alfranca A; Redondo JM; Hatae T; Tanabe T; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):63-9. PubMed ID: 17068288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of platelets with endothelial progenitor cells in the experimental atherosclerosis: Role of transplanted endothelial progenitor cells and platelet microparticles.
    Alexandru N; Andrei E; Dragan E; Georgescu A
    Biol Cell; 2015 Jun; 107(6):189-204. PubMed ID: 25763472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
    Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
    Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of peroxisome proliferator-activated receptor-{delta} enhances regenerative capacity of human endothelial progenitor cells by stimulating biosynthesis of tetrahydrobiopterin.
    He T; Smith LA; Lu T; Joyner MJ; Katusic ZS
    Hypertension; 2011 Aug; 58(2):287-94. PubMed ID: 21709207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes.
    Zheng Y; Voice JK; Kong Y; Goetzl EJ
    FASEB J; 2000 Dec; 14(15):2387-9. PubMed ID: 11024010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
    Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth.
    Xing Y; Ganji SH; Noh JW; Kamanna VS
    Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1250-7. PubMed ID: 15292052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane.
    Zheng Y; Kong Y; Goetzl EJ
    J Immunol; 2001 Feb; 166(4):2317-22. PubMed ID: 11160288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective non-lipid modulator of LPA5 activity in human platelets.
    Kozian DH; Evers A; Florian P; Wonerow P; Joho S; Nazare M
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5239-43. PubMed ID: 22801643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report.
    Ali FY; Hall MG; Desvergne B; Warner TD; Mitchell JA
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1871-3. PubMed ID: 19696401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Edg family LPA receptors: the cutting edge of LPA research.
    Yanagida K; Ishii S
    J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of PPARδ in bone marrow endothelial progenitor cells improves their hematopoiesis-supporting ability after myelosuppressive injury.
    Liang M; Lyu ZS; Zhang YY; Tang SQ; Xing T; Chen YH; Wang Y; Jiang Q; Xu LP; Zhang XH; Huang XJ; Kong Y
    Cancer Lett; 2024 Jun; 592():216937. PubMed ID: 38704134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lpar1-mediated Effects in Endothelial Progenitor Cells Are Crucial for Lung Repair in Acute Respiratory Distress Syndrome/Acute Lung Injury.
    Li N; Xu X; Qi Z; Gao C; Zhao P; Yang J; Damirin A
    Am J Respir Cell Mol Biol; 2023 Feb; 68(2):161-175. PubMed ID: 36287629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms.
    Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H
    Cell Signal; 2008 Oct; 20(10):1804-14. PubMed ID: 18627789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction.
    Rizza C; Leitinger N; Yue J; Fischer DJ; Wang DA; Shih PT; Lee H; Tigyi G; Berliner JA
    Lab Invest; 1999 Oct; 79(10):1227-35. PubMed ID: 10532586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.
    Li G; Mosier PD; Fang X; Zhang Y
    J Mol Graph Model; 2009 Aug; 28(1):70-9. PubMed ID: 19423373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.